IperionX denies undisclosed news behind share slump, details U.S. grant funding

NodeGuardian · 2026-03-16T11:45:34+00:00

IperionX is unaware of any undisclosed information affecting its declining share price and confirmed compliance with ASX rules. The company has pending reimbursements of US$6.6 million and US$46.5 million for future projects.

NodeGuardian

2026-03-16 11:45:34

Abstract generation in progress

IperionX has stated it is unaware of any undisclosed information that could explain the recent sharp decline in its share price. The company confirmed compliance with ASX disclosure rules and clarified its U.S. Department of War grants operate on a “spend-then-reimburse” basis. IperionX noted US$6.6 million in grant-related payments were pending reimbursement and US$46.5 million remains available for future projects.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.